Samir Megateli

Samir Megateli is an experienced professional in the pharmaceutical industry, currently serving as Franchise Head for Neuromuscular Diseases within the Enabling Rare & Gene Therapy Network at Roche. In this role, Samir Megateli also acts as Lifecycle Leader for Gene Therapy related to Duchenne in Global Product Strategy for Neuroscience & Rare Diseases. Previously, Samir Megateli held the position of Head of Sales and Strategy for Major & Established Products at Roche France. Prior to joining Roche, Samir Megateli worked at Sanofi, where responsibilities included Marketing Manager and Product Manager for cardiology products such as Plavix and Aprovel/CoAprovel.